Table 2 primary safety endpoint
Adverse events | Propofol group (n = 34) | Midazolam group (n = 35) | P-value |
|---|---|---|---|
Total (n, %) | 10 (29.4) | 8 (22.9) | .535 |
Bradycardia (n, %) | 3 (8.8) | 5 (14.3) | .479 |
Severe hypotension (n, %) | 5 (14.7) | 3 (8.6) | .426 |
Severe hypoxia (n, %) | 2 (5.9) | 0 (0) | .145 |
Neurologic event (n, %) | 0 (0) | 0 (0) | – |
Orotracheal intubation (n, %) | 0 (0) | 0 (0) | – |
Death (n, %) | 0 (0) | 0 (0) | – |